Michael Joseph Boyer
Children's Hospital of Philadelphia
2 papers in the Anchorcite directory, published in 2018, cited 12,654 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 1 paper
- Lung Cancer Diagnosis and Treatment · 1 paper
- Lung Cancer Treatments and Mutations · 1 paper
- CAR-T cell therapy research · 1 paper
- Immunotherapy and Immune Responses · 1 paper
- Acute Lymphoblastic Leukemia research · 1 paper
Frequent co-authors
- Leena Gandhi · 1 paper
- Delvys Rodríguez‐Abreu · 1 paper
- Shirish M. Gadgeel · 1 paper
- Emilio Esteban · 1 paper
- Enriqueta Felip · 1 paper
- Flávia De Angelis · 1 paper
- Manuel Dómine · 1 paper
- Philip R. Clingan · 1 paper
Papers
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung CancerNew England Journal of Medicine · 2018 · 6,754 citations
BACKGROUND: First-line therapy for advanced non-small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportion score for programmed death ligand 1 (PD-L1) of 50% or greater, pembrolizumab has replaced cytotoxic chemotherapy as the…
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaNew England Journal of Medicine · 2018 · 5,900 citations
BACKGROUND: In a single-center phase 1-2a study, the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel produced high rates of complete remission and was associated with serious but mainly reversible toxic effects in children and young adults with relapsed or…
Metadata from OpenAlex (CC0).